Bures-sur-Yvette, France

Isabelle Jullien


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle Jullien

Introduction

Isabelle Jullien is a notable inventor based in Bures-sur-Yvette, France. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on piperazine derivatives. Her research has led to the development of new compounds that have potential applications in medicine.

Latest Patents

Isabelle Jullien holds a patent for "Piperazine derivatives of theophylline and theobromine." This patent includes new compounds of formulas I and II, along with pharmaceutically acceptable acid addition salts. The compounds are characterized by specific groups, including hydrogen, morpholino, and benzylamino, among others. This patent represents her commitment to advancing pharmaceutical science and improving therapeutic options.

Career Highlights

Throughout her career, Isabelle has demonstrated a strong dedication to research and innovation. Her work at Recherche Syntex has allowed her to explore various aspects of pharmaceutical chemistry. She has focused on creating compounds that can enhance the efficacy of existing medications, showcasing her expertise in the field.

Collaborations

Isabelle has collaborated with esteemed colleagues such as Serge Beranger and J Claude Pascal. These partnerships have enriched her research and contributed to the successful development of her patented compounds.

Conclusion

Isabelle Jullien's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work continues to inspire advancements in medical science and showcases the importance of research and collaboration in driving innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…